We are live on ! Find out more
BXRX

Baudax Bio, Inc. Common Stock
BXRX

Delisted

BXRX was delisted on the 15th of November, 2023.

Back to rankings

12 hedge funds and large institutions have $127K invested in Baudax Bio, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

74% more capital invested

Capital invested by funds: $73.2K → $127K (+$53.9K)

20% more funds holding

Funds holding: 10 → 12 (+2)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
12
Holders Change
+2
Holders Change %
+20%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$83.5K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$63.3K
3
JP Morgan Chase
JP Morgan Chase
New York
+$3.84K
4
TRCT
Tower Research Capital (TRC)
New York
+$3.17K
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$2.69K

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$18.3K
2
UBS Group
UBS Group
Switzerland
-$9.57K
3
EDRH
Edmond de Rothschild Holding
Switzerland
-$226
4
Morgan Stanley
Morgan Stanley
New York
-$3

BXRX Hedge Fund Activity: Q1 2023 in Review

12 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Baudax Bio, Inc. Common Stock (BXRX) for Q1 2023, worth a combined $127K — up 74% from $73.2K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new BXRX positions and 2 closed out — a net gain of 2 holders — while 1 added to existing stakes and 2 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $83.5K. The largest seller was State Street, cutting an estimated $18.3K.

  • 12 institutional investors held Baudax Bio, Inc. Common Stock (BXRX) as of Q1 2023, up from 10 in Q4 2022.
  • Funds reported $127K of Baudax Bio, Inc. Common Stock stock for Q1 2023, up 74% quarter-over-quarter.
  • 4 funds opened new Baudax Bio, Inc. Common Stock positions in Q1 2023 and 2 closed out, a net change of +2 holders.
  • The largest Baudax Bio, Inc. Common Stock buyer in Q1 2023 was Susquehanna International Group, an estimated $83.5K added.
  • The largest Baudax Bio, Inc. Common Stock seller in Q1 2023 was State Street, an estimated $18.3K sold.

Based on aggregated 13F filings for Q1 2023.